CANCER 2026 Mark Bunting
South Australian Immunogenomics Cancer Institute, SA, Australia
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
Dysregulation of the tristetraprolin and NF-kappa B pathway contributes to estrogen receptor positive breast cancer treatment resistance. (#122)
5:40 PM
Mark D Bunting
Welcome Reception & Poster Session 1
Loss of tristetraprolin drives the progression to treatment resistant prostate cancer by altering stress response pathways (#221)
5:35 PM
Katherine L Morel
Poster Session 2